
Medicals Direct
Medical data to the insurance sector.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 Valuation: €0.0 5.5x EV/Revenue -84.0x EV/EBITDA | round | |
* | N/A | Acquisition | |
Total Funding | 000k |
GBP | 2009 | 2010 | 2011 | 2012 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | (6 %) | (4 %) | (2 %) |
EBITDA | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 1 % | 2 % | (12 %) | (6 %) |
Profit | 0000 | 0000 | 0000 | 0000 |
% profit margin | (13 %) | - | (15 %) | 411 % |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Founded in 1994, Medicals Direct emerged as a pioneering force in the UK healthcare sector, specializing in medical assessments and clinical tests. The company was co-founded by Jonathan Benton, who played a pivotal role in steering its growth and innovation.
Medicals Direct quickly established itself as a leader in providing medical evidence gathering services, leveraging secure and innovative technology to streamline processes. This approach not only enhanced efficiency but also set new standards in the industry.
A significant milestone in the company's journey occurred on May 21, 2012, when Medicals Direct was acquired by Capita. This acquisition marked a new chapter, providing the company with the resources and support to expand its services and reach.
Throughout its history, Medicals Direct has remained committed to delivering high-quality medical assessments and expert opinions, continually adapting to the evolving needs of the healthcare market. Today, it stands as a testament to the impact of strategic innovation and collaboration in transforming healthcare services.